Jerry Okikawa

453 total citations
14 papers, 371 citations indexed

About

Jerry Okikawa is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Jerry Okikawa has authored 14 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Physiology. Recurrent topics in Jerry Okikawa's work include Inhalation and Respiratory Drug Delivery (11 papers), Asthma and respiratory diseases (4 papers) and Diabetes Management and Research (3 papers). Jerry Okikawa is often cited by papers focused on Inhalation and Respiratory Drug Delivery (11 papers), Asthma and respiratory diseases (4 papers) and Diabetes Management and Research (3 papers). Jerry Okikawa collaborates with scholars based in United States, Denmark and Australia. Jerry Okikawa's co-authors include Stephen J. Farr, Reid Rubsamen, Laurence E. Mather, Peter Lloyd, Igor Gonda, Babatunde Otulana, John Thipphawong, Andrea Siebenhofer, Gernot Brunner and Martin Ellmerer and has published in prestigious journals such as Diabetologia, British Journal of Pharmacology and International Journal of Pharmaceutics.

In The Last Decade

Jerry Okikawa

14 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jerry Okikawa United States	10	270	112	89	63	49	14	371
Brian P. Betensky United States	11	100 0.4×	84 0.8×	111 1.2×	8 0.1×	45 0.9×	20	713
L. Ashworth United Kingdom	10	34 0.1×	240 2.1×	153 1.7×	22 0.3×	57 1.2×	13	417
R B Logan-Sinclair United Kingdom	7	220 0.8×	32 0.3×	255 2.9×	4 0.1×	27 0.6×	9	516
Achim Mueller United States	11	784 2.9×	9 0.1×	631 7.1×	15 0.2×	8 0.2×	21	873
Sarah D. Blumenschein United States	10	50 0.2×	41 0.4×	10 0.1×	39 0.6×	93 1.9×	16	591
Saket Gupta Ireland	10	141 0.5×	170 1.5×	31 0.3×	12 0.2×	59 1.2×	19	378
J. Soares United States	13	97 0.4×	19 0.2×	32 0.4×	12 0.2×	150 3.1×	32	362
Andjela Drincic United States	5	7 0.0×	158 1.4×	45 0.5×	8 0.1×	80 1.6×	8	337
Karl La Rosée Germany	11	61 0.2×	23 0.2×	32 0.4×	4 0.1×	56 1.1×	20	482
Amy J. Peleckis United States	11	187 0.7×	249 2.2×	14 0.2×	9 0.1×	234 4.8×	22	462

Countries citing papers authored by Jerry Okikawa

Since Specialization

Citations

This map shows the geographic impact of Jerry Okikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry Okikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry Okikawa more than expected).

Fields of papers citing papers by Jerry Okikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry Okikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry Okikawa. The network helps show where Jerry Okikawa may publish in the future.

Co-authorship network of co-authors of Jerry Okikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Jerry Okikawa. A scholar is included among the top collaborators of Jerry Okikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerry Okikawa. Jerry Okikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Eldon, Michael A., et al.. (2020). Safety, Tolerability, and Pharmacokinetics of RT234 (Vardenafil Inhalation Powder): A First-in-Human, Ascending Single- and Multiple-Dose Study in Healthy Subjects. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 34(4). 251–261. 6 indexed citations

Shrewsbury, Stephen B., et al.. (2008). Intrapulmonary and intravenous administrations of dihydroergotamine mesylate have similar cardiovascular effects in the conscious dog. British Journal of Pharmacology. 154(6). 1254–1265. 5 indexed citations

Davison, Sonia L., John Thipphawong, Jim Blanchard, et al.. (2005). Pharmacokinetics and Acute Safety of Inhaled Testosterone in Postmenopausal Women. The Journal of Clinical Pharmacology. 45(2). 177–184. 30 indexed citations

Otulana, Babatunde, et al.. (2004). Safety and pharmacokinetics of inhaled morphine delivered using the AERx System in patients with moderate-to-severe asthma. International Journal of Clinical Pharmacology and Therapeutics. 42(8). 456–462. 13 indexed citations

Cramer, Joyce A., et al.. (2004). Compliance with Inhaled Insulin Treatment Using the AERx ^® iDMS Insulin Diabetes Management System. Diabetes Technology & Therapeutics. 6(6). 800–807. 18 indexed citations

Boyd, Ben J., Peter D. Noymer, Kui Liu, et al.. (2004). Effect of Gender and Device Mouthpiece Shape on Bolus Insulin Aerosol Delivery Using the AERx Pulmonary Delivery System. Pharmaceutical Research. 21(10). 1776–1782. 8 indexed citations

Geller, David E., John Thipphawong, Babatunde Otulana, et al.. (2003). Bolus Inhalation of rhDNase with the AERx System in Subjects with Cystic Fibrosis. Journal of Aerosol Medicine. 16(2). 175–182. 18 indexed citations

Thipphawong, John, Babatunde Otulana, Per Clauson, Jerry Okikawa, & Stephen J. Farr. (2002). Pulmonary Insulin Administration Using the AERx ^® Insulin Diabetes System. Diabetes Technology & Therapeutics. 4(4). 499–504. 24 indexed citations

Okumu, Franklin W., Robert J. Lee, James Blanchard, et al.. (2002). Evaluation of the AERx Pulmonary Delivery System for Systemic Delivery of a Poorly Soluble Selective D-1 Agonist, ABT-431. Pharmaceutical Research. 19(7). 1009–1012. 9 indexed citations

10.

Brunner, Gernot, Martin Ellmerer, L. Schaupp, et al.. (2001). Dose-response relation of liquid aerosol inhaled insulin in Type I diabetic patients. Diabetologia. 44(3). 305–308. 88 indexed citations

11.

Farr, Stephen J., Simon Warren, Peter Lloyd, et al.. (2000). Comparison of in vitro and in vivo efficiencies of a novel unit-dose liquid aerosol generator and a pressurized metered dose inhaler. International Journal of Pharmaceutics. 198(1). 63–70. 41 indexed citations

12.

Farr, Stephen J., A. McElduff, Laurence E. Mather, et al.. (2000). Pulmonary Insulin Administration Using the AERx® System: Physiological and Physicochemical Factors Influencing Insulin Effectiveness in Healthy Fasting Subjects. Diabetes Technology & Therapeutics. 2(2). 185–197. 60 indexed citations

13.

Ward, Marcy, Laurence E. Mather, Stephen J. Farr, et al.. (1997). Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system*. Clinical Pharmacology & Therapeutics. 62(6). 596–609. 50 indexed citations

14.

Warren, Simon, Stephen J. Farr, George Taylor, et al.. (1996). Comparison of aerosol deposition from a solution MDI and a novel liquid aerosol generation in healthy volunteers. European Journal of Pharmaceutical Sciences. 4. S141–S141. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact